| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.17▲ | 8.12▲ | 8.08▲ | 7.99▲ | 8.08▲ |
| MA10 | 8.14▲ | 8.02▲ | 8.04▲ | 7.91▲ | 10.07▼ |
| MA20 | 8.11▲ | 8.03▲ | 8.06▲ | 8.04▲ | 11.26▼ |
| MA50 | 7.99▲ | 8.09▲ | 7.93▲ | 10.26▼ | 30.17▼ |
| MA100 | 8.05▲ | 7.91▲ | 7.99▲ | 11.29▼ | 33.41▼ |
| MA200 | 8.07▲ | 7.99▲ | 8.36▼ | 22.48▼ | 27.63▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.023▲ | 0.002▲ | 0.176▲ | 0.754▲ |
| RSI | 62.830▲ | 59.116▲ | 57.244▲ | 41.999▼ | 27.281▼ |
| STOCH | 88.333▲ | 79.364 | 61.316 | 46.258 | 5.435▼ |
| WILL %R | -20.000▲ | -8.889▲ | -8.889▲ | -29.703 | -90.125▼ |
| CCI | 131.227▲ | 92.114 | 75.857 | 29.622 | -89.387 |
|
Thursday, October 22, 2026 04:08 AM
Roth Capital Partners analyst Boobalan Pachaiyappan initiated coverage of Atrium Therapeutics ( Atrium Therapeutics, Stock Quote, Chart, News, Analysts, Financials NASDAQ:RNA) with a “Buy” rating and ...
|
|
Friday, October 02, 2026 03:24 AM
Novartis (NYSE:NVS) has entered into a licensing agreement with Chinese biotechnology company Abogen covering an experimental RNA-based therapy and other potential treatments developed using Abogen’s ...
|
|
Thursday, August 20, 2026 08:24 PM
SAN DIEGO, Aug. 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company") today announced it awarded inducement grants on August 20, 2026 under the Company's 2026 Employment ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/10/26 | 8.06 | 8.21 | 7.78 | 8.20 | 192,644 |
| 22/10/26 | 8.01 | 8.185 | 7.945 | 8.16 | 173,379 |
| 21/10/26 | 7.97 | 8.32 | 7.96 | 8.00 | 193,206 |
| 20/10/26 | 7.75 | 8.27 | 7.71 | 7.98 | 289,488 |
| 19/10/26 | 7.68 | 7.87 | 7.49 | 7.61 | 243,911 |
| 16/10/26 | 7.79 | 8.06 | 7.67 | 7.67 | 190,974 |
| 15/10/26 | 7.75 | 7.87 | 7.64 | 7.82 | 131,235 |
| 14/10/26 | 7.75 | 7.935 | 7.54 | 7.68 | 269,490 |
| 13/10/26 | 8.22 | 8.22 | 7.75 | 7.75 | 236,583 |
| 12/10/26 | 8.40 | 8.4815 | 8.21 | 8.21 | 87,396 |
|
|
||||
|
|
||||
|
|